Application no. and date | 15727884.7 (espacenet) (Federated) (European Patent Register), 20150427 | Patent/reg. no. and date | DK/EP 3134438, 20200930 | Publication date | 20170301 | Priority no. and date | US 201461984160 P, 20140425 | EP pub. no. and date |
EP 3134438 20170301 | Effective date | | Applicant/owner | Pierre Fabre Médicament, 45, Place Abel Gance 92100 Boulogne-Billancourt, FR | Applicant ref. no. | V51036DK00 | Inventor | GOETSCH, Liliane, 15 Route de Cluze
74130 Ayze, FR, BROUSSAS, Matthieu, 13b Rue du Lieutenant Bovagne Immeuble les Terrasses
01420 Seyssel, FR, CHAMPION, Thierry, 4 Avenue de la Gare Immeuble le Quai d'Armand
74160 Saint Julien en Genevois, FR, ROBERT, Alain, 12 Rue de Romagny
74100 Annemasse, FR, BEAU-LARVOR, Charlotte, 156 Rue du Champs à la Moine Hameau de Vigny
74520 Jonzier Epagny, FR | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | IGF-1R-antistof og anvendelse heraf som adresseringsvehikel til behandling af cancer | Int. application no. | EP2015059050 | Int. publication no. | WO2015162292 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|